Views Navigation

Event Views Navigation

Today

Xylazine and How it Harms People Who Use Drugs

Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review what is known to date on Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This […]

Opioid Use Disorder and Social Determinants of Health

Presenters:   Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social Justice and Health Equity Curriculum Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: Council for Mental Wellbeing will not be providing Continuing Medical Education […]

Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders

Join us on Wednesday, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter, PhD, MPH, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will present "Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders." Dr. Richter received her Master of Public Health from the University […]

Drug Use in Pregnancy (ASAM FAME Session 7)

Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, MD Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated, […]

Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers

This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment, particularly in rural communities. It will also explore barriers and facilitators regarding nurse practitioner engagement in buprenorphine treatment, including regulations, education, and broader social factors such as stigma. Specific considerations for advanced practice clinicians' work with […]

Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape

Register Now Presenters: Maria Manriquez, MD, FACOG, FASAM, PMH-C; Tara Sundem, APRN, NNP-BC; and Tawni Carson Sponsor: National Council for Mental Wellbeing--NCMW NOTE: The National Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. Target Audience: This activity is designed for interprofessional teams, families and patients, students and educators, nurses, […]

Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations

This presentation will describe research around syringe service programs and methods of harm reduction distribution. Specific considerations for reaching members of rural communities will be discussed. Learning objectives: 1. Discuss the need for novel approaches for distributing harm reduction supplies 2. Describe benefits and challenges regarding syringe service programs 3. Outline specifics of programs that […]

A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior

This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for substance use disorder, including in rural areas. Register and attend to learn more! Speaker: Barbara "Basia" Andraka-Christou, PhD, JD, Assistant Professor in the School of […]

Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective

Presenters: Mark Parrino, President and CEO of The American Association for the Treatment of Opioid Dependence, Inc. Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health Sponsor: National Council for Mental Wellbeing--NCMW Credit designational available: None Target Audience: Interprofessional teams, patients, educators, nurses, physicians, psychiatrists, psychologists, executives, clinical staff, administrators and social […]

Buprenorphine in the Age of Fentanyl: Discussing the New Guidance

Presenter: John Mariani, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

Reaching People Where They’re At: Smoking Cessation Treatment Delivery at Your Door

This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling, each demonstrating feasibility and efficacy of a simple yet novel treatment approach to reach a broad spectrum of smokers, including those who may not yet want […]

Clinical Primer and Discussion on Weekly and Monthly Injectable Buprenorphine

Presenter: Michelle Lofwall, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

Buprenorphine Dosing and Preparations in the Era of Fentanyl

Presenters: Gail D’Onofrio, MD and Andrew Herring, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register […]

Ready or Not Here Come the Nitazenes

Presenter: Edwin Salsitz, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]

Women & Alcohol: What does stress have to do with it?

Join us on Wednesday, November 15th for the #VCBHLectureSeries as we welcome Sherry McKee, PhD, Director, Yale Behavioral Pharmacology Laboratory. Dr. McKee will present "Women & Alcohol: What does stress […]

Collaborative Care Model (CoCM) for Substance Use Disorders

Presenters: Anna Ratzliff, MD, PhD; Jasen Christensen, DO Webinar Description This presentation will review the Collaborative Care Model (CoCM), which is an evidence-based approach to delivering behavioral healthcare in primary […]

Overdose-related Compassion Fatigue in Rural Communities

Erin Winstanley, PhD Visiting Professor, University of Pittsburgh School of Medicine Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, she has postdoctoral training […]

Treating Adolescents with Substance Use Disorder

Presenter: Marc Fishman, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]

Northern New England ASAM Annual Conference

Conference Agenda Day One: 5 PM – 6:30 PM:            Conference Check-in and Welcome Reception Refreshments and social hour. 6:30 PM – 7:30 PM:     […]

$25 – $150

Northern New England ASAM Annual Conference

Conference Agenda Day Two: 8:30 AM – 8:45 AM:    Welcome Remarks Clifton “Fred” Lord MD, President of NNESAM, ASAM Fellow, Board Certified in Addiction Medicine, CEO/Medical Director/Chairman of the […]

$25 – $150

Telemedicine and Treating Opioid Use Disorder in Rural Populations

Presenter: Greg Greenberg, MD Sponsor: American Academy of Addiction Psychiatry (AAAP) Cost: No Fee Target audience: This activity is designed for counselors, physician assistants, physicians, and psychiatrists. This activity is accredited for […]